XML 27 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Intangible Assets, Net
 6 Months Ended
Sep. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net
Goodwill and Intangible Assets, Net
Changes in the carrying amount of goodwill were as follows:
(In millions)
U.S. Pharmaceutical and Specialty Solutions
 
European Pharmaceutical Solutions
 
Medical-Surgical Solutions
 
Other
 
Total
Balance, March 31, 2018
$
4,110

 
$
1,850

 
$
2,070

 
$
2,894

 
$
10,924

Goodwill acquired
—

 
37

 
360

 
5

 
402

Goodwill impairment charges
—

 
(570
)
 
—

 
—

 
(570
)
Acquisition accounting, transfers and other adjustments
13

 
1

 
15

 
6

 
35

Foreign currency translation adjustments, net
(40
)
 
(108
)
 
—

 
(16
)
 
(164
)
Balance, September 30, 2018
$
4,083

 
$
1,210

 
$
2,445

 
$
2,889

 
$
10,627


As of September 30, 2018, accumulated goodwill impairment losses were $1,776 million and $456 million in our European Pharmaceutical Solutions segment and Other. As of March 31, 2018, accumulated goodwill impairment losses were $1,299 million and $456 million in our European Pharmaceutical segment and Other. Refer to Financial Note 3, “Goodwill Impairment Charges,” for more information on goodwill impairment charges.
Information regarding intangible assets is as follows:
 
September 30, 2018
 
March 31, 2018
(Dollars in millions)
Weighted
Average
Remaining
Amortization
Period
(years)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer relationships
12
 
$
4,036

 
$
(1,797
)
 
$
2,239

 
$
3,619

 
$
(1,550
)
 
$
2,069

Service agreements
12
 
1,027

 
(406
)
 
621

 
1,037

 
(386
)
 
651

Pharmacy licenses
25
 
777

 
(357
)
 
420

 
684

 
(196
)
 
488

Trademarks and trade names
14
 
925

 
(223
)
 
702

 
932

 
(187
)
 
745

Technology
4
 
141

 
(86
)
 
55

 
147

 
(84
)
 
63

Other
5
 
288

 
(197
)
 
91

 
262

 
(176
)
 
86

Total
 
 
$
7,194


$
(3,066
)
 
$
4,128

 
$
6,681

 
$
(2,579
)
 
$
4,102


Amortization expense of intangible assets was $121 million and $243 million for the second quarter and six months ended September 30, 2018 and $126 million and $247 million for the second quarter and six months ended September 30, 2017. Estimated annual amortization expense of these assets is as follows: $228 million, $443 million, $420 million, $405 million and $339 million for the remainder of 2019 and each of the succeeding years through 2023 and $2,293 million thereafter. All intangible assets were subject to amortization as of September 30, 2018 and March 31, 2018.